Kontakt 2005, 7(3-4):338-343 | DOI: 10.32725/kont.2005.065
Depression and antidepressantsBiomedicine
- 1 Ústav lékařské etiky, Masarykova univerzita, Brno
- 2 Jihočeská univerzita v Českých Budějovicích, Zdravotně sociální fakulta, katedra radiologie a toxikologie
Depression is a disease affecting both the body and the state of mind and the thinking. It influences sleep and eating habits, the way of perception of oneself as well as perception of surrounding world. Depression is not a symptom of personal weakness or a condition we could get rid of by mere wish or will involvement. People suffering from depression cannot simply "pull themselves together" and relax. It is typical that depressive disturbances occur in different forms. Symptom complexes can remain during weeks, months or years, when they are not treated. On the other hand, adequate treatment can help the majority of the population suffering from depressions. Different types of antidepressants are available, including the newest ones as - serotonine-retrograde-uptake inhibitors (SSRIs) - as well as tricyclic antidepressants and mono-amino-oxidase inhibitors (MAOIs). SSRIs, as well as further newer medicines influencing the neurotransmitters - e.g. dopamine or noradrenaline - have generally more undesirable effects than tricyclic antidepressants. Appropriately chosen psychotherapy combined with appropriate antidepressant can contribute substantially to improvement of life quality in persons suffering from depressions.
Keywords: depression; mood; psychotherapy; antidepressants; life quality
Published: November 22, 2005 Show citation
References
- Bagby R. M., Ryder A. G., Schuller D. R., Marshall M. B. 2004: The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 161: 2163-2177.
Go to original source...
Go to PubMed...
- Češková E. 1994: Biologické markery deprese. Čas. Lék. Čes. 133: 99-102.
- Harter M. C., Conway K. P., Merikangas K. R. 2003: Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci. 253: 313-320.
Go to original source...
Go to PubMed...
- Herman E. 2004: Rozdíly mezi unipolární a bipolární depresí. In: Kolektiv: Depresivní onemocnění. 5-14, Praha: MAXDORF.
- Höschl C. 1999: Teorie deprese. Vesmír 78: 607.
Go to original source...
- Kratochvíl S. 1995: Skupinová psychoterapie v praxi. Praha: Galén.
- Leonhard K. 1979: The classification of endogenous psychoses. 5th ed. New York, London, Sydney, Toronto: Irvington Publishers.
- Murray C. J. L., Lopez A. D. 1996: The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press.
- Patočka J., Strunecká A. 2003: Standardizovaný extrakt třezalky tečkované: nové rostlinné antidepresivum. Voj. Zdrav. Listy 72: 114-118.
- Pidrman V. 2004: Deprese a kardiovaskulární onemocnění. In: Kolektiv: Depresivní onemocnění. 66-73, Praha: MAXDORF.
- Raboch J., Jirák R., Paclt I. 2005: Psychofarmakologie pro praxi. Praha: Triton.
- Raboch J., Pavlovský P. 1999: Psychiatrie (minimum pro praxi). Praha: Triton, ISBN 80-85875-98-5
- Raboch J., Zvolský P. et al. 2001: Psychiatrie. Praha: Galén, ISBN 80-7262-140-8 (Galén), ISBN 80-246-0390-X (Karolinum).
- Roth J., Preiss M., Uhrová T. 1999: Deprese v neurologické praxi. Praha: Galén.
- Strunecká A. 2002: Deprese, meditace a vědomí. Psyche et Natura, Praha, 106 - 123.
- Surawy C., Roberts J., Silver A. 2005: The effect of mindfulness training on mood and measures of fatigue, activity, and quality of life in patients with chronic fatigue syndrome on a hospital waiting list: A series of exploratory studies. Behav. Cogn. Psychoterapy 33: 103-109.
Go to original source...
- Zhang X., Gainetdinov R. R, Beaulieu J. M., Sotnikova T. D., Burch L. H., Williams R. B., Schwartz D. A., Krishnan K. R. and Caron M. G. 2005: Loss-of-function mutation in tryptophan hydroxylase-2 Identified in unipolar major depression. Neuron 45, 11 - 16.
Go to original source...
Go to PubMed...